Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aacf44bdf7ff68a9716dde630283cbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c0ff61ee9e7280e509a45c72d04d037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbfd78383a97c84a3ede91d1cd1ddcd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c159a3ca615b62ee646a02e39f8cd1 |
publicationDate |
2016-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016289225-A1 |
titleOfInvention |
Pyridinylpyrazoloquinoline compounds |
abstract |
A compound represented by formula (I), or a pharmaceutically acceptable salt thereof: n n n n n n n n n n wherein R 1 represents a group represented by the formula: n n n n n n n n n n a group represented by the formula: n n n n n n n n n n or a group represented by the formula: n n n n n n n n n n and R 2 represents a 3-methyltetrahydro-2H-pyran-4-yl group or 4-methoxycyclohexyl group. |
priorityDate |
2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |